It presents as a poorly differentiated tumor that requires demonstration of a fusion rearrangement between the NUTM1 gene and a variety of partners for diagnosis.1 The tumor can occur at any age, although it is seen most frequently in adolescents and young adults, with a median age of 24.2 Much effort has been invested in determining effective treatment for this disease. Here, NUTM1 is linked to neoplasm.